1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Astrocytosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, J; Feng, SQ; Gao, Z; Gozal, D; Liu, Y; Shields, CB; Shields, LBE; Wang, Y; Zhang, Y; Zhao, YZ; Zhu, Q | 1 |
Clayette, P; Dash, PK; Dong, CZ; Dou, H; Eggert, D; Gelbard, HA; Gendelman, HE; Gorantla, S; Heymans, F; Poluektova, L; Serradji, N | 1 |
Koike, T; Tanaka, S | 1 |
Gearing, A; Gendelman, HE; Limoges, J; Persidsky, Y; Rasmussen, J; Zheng, J | 1 |
Brodie, C; Kentroti, S; Lee, K; Vernadakis, A | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Astrocytosis
Article | Year |
---|---|
Role of astrocytes in aging: late passage primary mouse brain astrocytes and C-6 glial cells as models.
Topics: Aging; Animals; Astrocytes; Biological Factors; Brain; Brain Neoplasms; Cell Communication; Cells, Cultured; Chick Embryo; Culture Media, Serum-Free; Glioma; Gliosis; Mice; Muscles; Neoplasm Proteins; Nerve Tissue Proteins; Neuronal Plasticity; Neurons; Phenotype; Platelet Activating Factor; Rats; Tumor Cells, Cultured | 1992 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Astrocytosis
Article | Year |
---|---|
Attenuated Reactive Gliosis and Enhanced Functional Recovery Following Spinal Cord Injury in Null Mutant Mice of Platelet-Activating Factor Receptor.
Topics: Animals; Astrocytes; Axons; Cervical Vertebrae; Extracellular Matrix; Female; Forelimb; Gliosis; Inflammation; Mice, Inbred C57BL; Mice, Knockout; Microglia; Myelin Sheath; Neuronal Plasticity; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Recovery of Function; Spinal Cord Injuries | 2016 |
Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders.
Topics: AIDS Dementia Complex; Animals; Anti-Inflammatory Agents; Brain; Cell Death; Cells, Cultured; Cognition Disorders; Disease Models, Animal; Focal Adhesion Kinase 2; Giant Cells; Gliosis; Humans; Immunologic Factors; Inflammation Mediators; Male; Mice; Mice, SCID; Microglia; Monocytes; NF-kappa B; Piperazines; Platelet Activating Factor | 2009 |
Selective inflammatory stimulations enhance release of microglial response factor (MRF)-1 from cultured microglia.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Calcium Signaling; Calcium-Binding Proteins; Cell Communication; Cells, Cultured; Chemotaxis; Culture Media, Conditioned; Encephalitis; Enzyme Inhibitors; Gliosis; Inflammation Mediators; Ionophores; Microfilament Proteins; Microglia; Nerve Tissue Proteins; Neurons; Platelet Activating Factor; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Up-Regulation | 2002 |
Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis.
Topics: AIDS Dementia Complex; Animals; Benzyl Compounds; Cell Survival; Dexamethasone; Disease Models, Animal; Drug Combinations; Gliosis; HIV-1; Humans; In Vitro Techniques; Interleukin-1; Interleukin-8; Leucine; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, SCID; Microglia; Neurons; Pentoxifylline; Platelet Activating Factor; Protease Inhibitors; Succinates; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2001 |